---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-098354"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2025-10-09T23:59:59+00:00"
generated_at: "2026-05-17T04:11:09.104860+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# TELA Bio board changes: Lisa Colleran resigns, Dr. Betty Jo Rocchio appointed

## Summary
- Lisa Colleran resigned from the board on Oct 4, 2025; no disagreement with company.
- Dr. Betty Jo Rocchio appointed effective Oct 9, 2025; she is EVP, Chief Executive Nurse at Advocate Health.
- Initial equity award: option for 17,550 shares vesting monthly over 3 years; RSU for 11,925 shares vesting annually over 3 years.
- Annual retainer $45,000; starting 2026: annual award of option for 11,700 shares and RSU for 7,950 shares.

## SEC filing metadata
- accession: 0001104659-25-098354
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2025-10-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465925098354/0001104659-25-098354-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465925098354/tm2528308d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-098354
- JSON: https://secwatch.observer/filing/0001104659-25-098354.json
- Plain text: https://secwatch.observer/filing/0001104659-25-098354.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.